Accretion Nutraveda IPO GMP & Allotment
Accretion Nutraveda is a SME IPO with a price band of Rs 122.00 to Rs 129.00 that listed on 04 Feb 2026 at a listing gain of +48.06%. Track its full GMP history, subscription data and listing details here.
- IPO Price Band
- ₹122.00 - ₹129.00
- Lot Size
- 1,000 Shares
- Bidding Closes
- 30 Jan 2026
- Listing Date
- 04 Feb 2026
Complete IPO information
| IPO Open Date | 28 Jan 2026 |
|---|---|
| IPO Close Date | 30 Jan 2026 |
| IPO Price Band | ₹122.00 - ₹129.00 |
| Lot Size | 1,000 Shares |
| Current GMP | ₹62 |
| Estimated Listing Gain | +48.06% |
| Issue Size | - |
| Fresh Issue | - |
| Issue Type | SME |
| IPO Listing | NSE, BSE |
| Retail Quota | TBA |
| Registrar | TBA |
| Overall Subscription | TBA |
| Minimum Investment | ₹2,58,000 |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus | - |
IPO Snapshot & Investor Takeaways
At the upper end of its price band, Accretion Nutraveda is priced at ₹129 per share. With a minimum lot size of 1,000 shares, a retail investor applying for one lot would need approximately ₹2,58,000 to participate in this SME issue.
The latest recorded Grey Market Premium for Accretion Nutraveda stands at ₹62, implying an estimated listing gain of around 48.06% over the issue price if it holds until listing. This is up ₹53 from its previously recorded level. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.
IPO roadmap at a glance
Daily GMP status
| Date | GMP | Change | Gain |
|---|---|---|---|
| 04 Feb 2026 | ₹69.00 | +₹53.00 | 53.49% |
| 03 Feb 2026 | ₹16.00 | +₹10.00 | 12.40% |
| 02 Feb 2026 | ₹6.00 | - | 4.65% |
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 Lot | 2,000 | ₹2,58,000 |
| Retail Maximum | 2 Lot | 2,000 | ₹2,58,000 |
| S-HNI Minimum | 3 Lot | 3,000 | ₹3,87,000 |
| S-HNI Maximum | 7 Lot | 7,000 | ₹9,03,000 |
| B-HNI Minimum | 8 Lot | 8,000 | ₹10,32,000 |
Objects of the Issue & Official Documents
Accretion Nutraveda IPO – Market Lot Details
| Application | Lot Size | Shares | Amount (₹) |
|---|---|---|---|
| Retail Minimum | 2 | 2,000 | 2,58,000 |
| Retail Maximum | 2 | 2,000 | 2,58,000 |
| S‑HNI Minimum | 3 | 3,000 | 3,87,000 |
| S‑HNI Maximum | 7 | 7,000 | 9,03,000 |
| B‑HNI Minimum | 8 | 8,000 | 10,32,000 |
Accretion Nutraveda IPO – Reservation Details
| Investor Category | Shares Offered | Percentage (%) |
|---|---|---|
| Anchor Investors | – | – |
| QIB (Ex‑Anchor) | 9,08,000 | 47.29% |
| NII | 2,76,000 | 14.37% |
| Retail | 6,40,000 | 33.33% |
Accretion Nutraveda IPO Dates
| Particular | Dates |
|---|---|
| IPO Open Date | 28 Jan 2026 |
| IPO Close Date | 30 Jan 2026 |
| Basis of Allotment | - |
| Refunds | - |
| Credit to Demat Account | - |
| IPO Listing Date | 04 Feb 2026 |
Note: The timeline for Accretion Nutraveda IPO is tentative and subject to change.
Accretion Nutraveda IPO – Important Dates
| IPO Open Date | January 27, 2026 |
| IPO Close Date | January 30, 2026 |
| Basis of Allotment | February 2, 2026 |
| Refunds Initiation | February 3, 2026 |
| Credit to Demat Account | February 3, 2026 |
| IPO Listing Date | February 4, 2026 |
| IPO Bidding Cut‑off Time | January 30, 2026 – 5:00 PM |
Accretion Nutraveda Objects of the Issue & Utilisation of Proceeds
To Be Updated Soon
Accretion Nutraveda IPO – Objects of the Issue & Utilisation of Proceeds
| Purpose | Amount (₹ Cr) |
|---|---|
| Purchase of machineries for automation in existing manufacturing unit | 4.22 |
| Purchase of machineries for new manufacturing setup | 8.03 |
| Funding working capital requirements of the company | 5.50 |
| General Corporate Purpose | – |
Accretion Nutraveda Company Financials
To Be Updated Soon
Accretion Nutraveda Company Valuation – FY2026
To Be Updated Soon
Accretion Nutraveda IPO Peer Group Comparison
To Be Updated Soon
Accretion Nutraveda IPO – Peer Group Comparison
| Company | EPS (₹) | P/E Ratio | RoNW (%) | NAV (₹) | Income (₹ Cr) |
|---|---|---|---|---|---|
| Walpar Nutritions Ltd. | 1.80 | 23.94 | 11.27% | 13.65 | 60.26 |
| Influx Healthtech Limited | 7.31 | 25.93 | 36.72% | 5.31 | 104.99 |
IPO Lead Managers aka Merchant Bankers
- Sobhagya Capital Options Pvt. Ltd.
Compare Accretion Nutraveda IPO with similar IPOs
Accretion Nutraveda IPO FAQs
Comments
Share a useful question or insight about Accretion Nutraveda.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Loading comments...